A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondroplasia.
Abroad (travel likely)RecruitingPHASE2
Conditions
Achondroplasia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Ascendis Investigational Site, Montreal, Canada
Ascendis Investigational Site, Copenhagen, Denmark
Ascendis Investigational Site, Paris, France
Ascendis Investigational Site, Dublin, Ireland
Ascendis Investigational Site, Norwich, United Kingdom
Study leads
Medical Director, MD
Study Director
Ascendis Pharma A/S